New Zealand markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.5150-0.1950 (-7.18%)
As of 02:50PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. Estimate-0.09-0.07-0.45-0.36
Low estimate-0.11-0.09-0.79-0.91
High estimate-0.07-0.05-0.2-0.02
Year ago EPS-0.27-0.35-0.8-0.45
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate32.8M34.37M145.93M175.5M
Low estimate30.9M32.3M138M171.2M
High estimate34.4M37.1M151.3M180.3M
Year ago sales29.61M31.76M127.04M145.93M
Sales growth (year/est)10.80%8.20%14.90%20.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.2-0.23-0.29-0.16
Actual EPS-0.27-0.35-0.17-0.07
Difference-0.07-0.120.120.09
Surprise %-35.00%-52.20%41.40%56.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.09-0.07-0.45-0.36
7 days ago-0.09-0.07-0.45-0.36
30 days ago-0.09-0.07-0.45-0.36
60 days ago-0.11-0.09-0.43-0.22
90 days ago-0.09-0.07-0.37-0.16
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesHRTXIndustrySector(s)S&P 500
Current qtr.66.70%N/AN/AN/A
Next qtr.80.00%N/AN/AN/A
Current year43.80%N/AN/AN/A
Next year20.00%N/AN/AN/A
Next 5 years (per annum)47.50%N/AN/AN/A
Past 5 years (per annum)-43.36%N/AN/AN/A